Tmwtfs Pfe Version

Pfizer (PFE): Average: Revenues ($mil): -2.04% Core Operating Costs: -3.46% Net Income:

2008

2007

2006

$48,296.00 -0.25% $30,594.00 -12.47% $8,104.00

$48,418.00 0.10% $34,954.00 13.38% $8,144.00

$48,371.00 -5.71% $30,828.00 -16.05% $19,337.00

ROE: Gross Margin: Profit Margin:

16.1% 32.03% 22.19%

12.0% 36.65% 16.78%

12.5% 27.81% 16.82%

27.1% 36.27% 39.98%

SGAE as % of net sales: Annual Change (%):

32.46% -1.60%

30.10% -6.73%

32.27% 0.14%

32.23% -2.73%

R&D ($mil): R&D as % of net sales: Annual Change (%):

15.60% 0.91%

$7,945.00 16.45% -1.78%

$8,089.00 16.71% 6.45%

$7,599.00 15.71% 2.11%

19.6% 55.1% 4.36%

1.20 1.28 10.3% 106.7% 7.23%

2.20 1.16 20.8% 52.7% 5.09%

2.06 0.96 26.3% 46.6% 3.71%

0.11 $9.95 3.6% $17.71 14.76 1.78

0.11 $9.60 -3.8% 2.15 $22.77 10.35 2.37

0.08 $9.98 12.4% 2.16 $25.90 12.57 2.60

91.5% 5.8% 2.7%

91.8% 5.4% 2.8%

93.2% 4.8% 2.0%

EPS: Dividends: Annual Change (%): Payout: Yield: LT Debt/Equity: BVPS: Annual Change (%): Current Ratio: Year End Price: Price-to-Earnings: Price-to-Book: Sales by Business Segment: Pharmaceutical: Animal Health: Corporate:

0.10 2.5%

12.38

2005

2004

$51,298.00 -2.32% $36,720.00 1.31% $8,085.00

$52,516.00

12.3% 28.42% 15.76%

16.6% 30.98% 21.63%

33.13% 2.94%

32.19%

$7,442.00 14.51% -3.15%

$7,684.00 14.63%

2.02 0.76 11.8% 37.6% 3.26%

2.12 0.68

0.10 $8.88 -2.4% 1.47 $23.32 11.54 2.63

93.4% 4.6% 2.0%

$36,245.00 $11,361.00

32.1% 2.53% 0.11 $9.10 1.48 $26.89 12.68 2.95